Treatment-resistant depression |
Clinically impairing depression symptoms despite an adequate trial of an evidence-based psychotherapy and an antidepressant with Grade A evidence for treating depression in pediatric population (fluoxetine, escitalopram, or sertraline) |
Treatment-refractory depression |
Clinically impairing depression symptoms despite an adequate trial of an evidence-based psychotherapy and at least 2 antidepressants with Grade A evidence for treating depression including at least 1 with Grade A evidence in pediatric populations (fluoxetine, escitalopram, or sertraline) |
Remission |
Minimal symptoms of depression after treatment |
Response |
Substantial improvement in depression symptoms with treatment. Greater than a 50% improvement in depression symptoms |
Partial response |
Modest improvement in depression symptoms with treatment. Defined as a 25%–49% improvement in depression symptoms |
Nonresponse |
Minimal-to-no improvement in depression symptoms with treatment. Defined as a less than 25% improvement in depression symptoms |